The GCE4All Center: Unleashing the Potential of Genetic Code Expansion for Biomedical Research
Project Number3RM1GM144227-02S1
Former Number5RM1GM144227-02
Contact PI/Project LeaderMEHL, RYAN A
Awardee OrganizationOREGON STATE UNIVERSITY
Description
Abstract Text
EQUIPMENT SUPPLEMENT ABSTRACT
The GCE4All Biomedical Technology Development and Dissemination Center at Oregon State University (OSU)
serves to optimize, develop, and broadly disseminate Genetic Code Expansion (GCE) technology – the
engineering of cellular translation to express proteins containing non-canonical amino acids (ncAAs). During its
envisioned lifespan of ≤15 years, the Center's mission is to effectively extend existing GCE technologies for facile
use by non-specialists, and to broadly disseminate them via widespread education, effective training, and by
providing sustainable access to optimized technologies via established repositories – enabling powerful GCE
approaches to become standard, widely-used tools of biomedical researchers. As we build new GCE encoding
systems, quantifying the intact mass of the ncAA-proteins is critical to verify the site-specific encoding of ncAAs,
to verify that there is no loss in fidelity by mis-encoding of natural amino acids, and to evaluate biorthogonal
labeling reactions on proteins. However, the center does not have equipment to characterize intact protein mass.
The university MS facility has two MS systems capable of intact protein mass characterization, an old Waters Q-
Tof MS system soon to be decommissioned and a high res-Q-TOF Lumos system. This facility unfortunately is
not able to provide the daily or weekly access for analysis of intact protein mass needed by the center and they
cannot accommodate walk up service from center staff. Here, we request funds to acquire a benchtop MS system,
6230B TOF MS system with ESI source and 1290 LCMS system with autosampler from Agilent. A center housed
MS system capable of intact protein mass analysis would allow us to quickly evaluate proteins from the center
and DBP labs. We expect the instrument will serve 50-100 researchers per year, including all personnel in the
center, DBP collaborators and 2 workshops of 20 people per year. A permanent center staff member will be
assigned to MS equipment maintenance and user training. The in-house ability to run and process our own intact
protein MS analysis on a daily basis will greatly accelerate the center mission regarding GCE technology
development, optimization and dissemination for DBPs and GCE trainees.
The summary of our original grant is included in our research strategy document.
Public Health Relevance Statement
Narrative for Genetic Code Expansion Center
The Genetic Code Expansion Biomedical Technology Development and Dissemination Center will allow
biomedical researchers around the world to have access to better scientific tools to generate specially designed
forms of proteins for probing and visualizing how life works. This will help them better determine how and
where biological processes go wrong to cause cancer, heart disease, pain, diabetes, Parkinson's disease, and
many other diseases, and will also drive new innovations and enable the development of more sensitive and
specific diagnostic tests and more effective drugs.
No Sub Projects information available for 3RM1GM144227-02S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3RM1GM144227-02S1
Patents
No Patents information available for 3RM1GM144227-02S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3RM1GM144227-02S1
Clinical Studies
No Clinical Studies information available for 3RM1GM144227-02S1
News and More
Related News Releases
No news release information available for 3RM1GM144227-02S1
History
No Historical information available for 3RM1GM144227-02S1
Similar Projects
No Similar Projects information available for 3RM1GM144227-02S1